SEC Form 4 reporting owner

Matrix Capital Management Company, LP

Matrix Capital Management Company, LP has filed 2 Form 4 transactions reported between December 15, 2025 and May 7, 2026, as 10% owner of Aura Biosciences, Inc. and 10% owner of Zentalis Pharmaceuticals, Inc..

Name as filed: Matrix Capital Management Company, LP

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$49.0M
2 lines
Companies
2
with Form 4 filings
Latest transaction
May 7, 2026
transaction date

Roles and reported holdings

  • AURAAura Biosciences, Inc.
    May 7, 2026

    10% owner

    Held indirectly (latest line)0 sh as of May 7, 2026 · Form 4

    24 months: $39.0M sold

  • ZNTLZentalis Pharmaceuticals, Inc.
    Dec 15, 2025

    10% owner

    Held indirectly (latest line)6,459,973 sh as of Dec 15, 2025 · Form 4

    24 months: $10.0M sold

Transaction history

All 2 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
May 7, 2026AURA10% ownerOpen-market saleCode S · indirect6,922,870$39.0M@ $5.64Form 4
Dec 15, 2025ZNTL10% ownerOpen-market saleCode S · indirect7,500,000$10.0M@ $1.33Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.